REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation — E Wesley ELY (VANDERBILT UNI
PROJECT SUMMARY/ABSTRACT Cognitive impairment, including Alzheimer’s Disease and Related Dementias (ADRD), and cardiopulmonary dysfunction following COVID-19, are components of the chronic syndrome kn
| Project title | REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation |
|---|---|
| Project number | 1R01AG085873-01 |
| PI name | E Wesley ELY |
| Institution | VANDERBILT UNIVERSITY MEDICAL CENTER |
| Funding mechanism | R01 |
| Agency | NIA |
| Award amount | $5.67M |
| Fiscal year | 2024 |
| Project start | 2024-01-01T00:00:00 |
| Project end | 2028-12-31T00:00:00 |
| Abstract | PROJECT SUMMARY/ABSTRACT Cognitive impairment, including Alzheimer’s Disease and Related Dementias (ADRD), and cardiopulmonary dysfunction following COVID-19, are components of the chronic syndrome kn |
| Key terms | <(TNF)-α><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><21+ years old><AD related deme |
$799/mo
Try GrantRadar →